Current Report Filing (8-k)
December 02 2021 - 07:51AM
Edgar (US Regulatory)
0000886744 false 0000886744 2021-11-30
2021-12-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of Report
(Date of earliest event reported):
December 1, 2021
GERON CORPORATION
(Exact name of
registrant as specified in its charter)
Delaware |
000-20859 |
75-2287752 |
(State
or other jurisdiction of |
(Commission File
Number) |
(IRS
Employer Identification No.) |
incorporation) |
|
|
919 E. HILLSDALE BLVD.,
SUITE 250
FOSTER CITY, california
94404
(Address of
principal executive offices, including zip code)
(650)
473-7700
(Registrant’s
telephone number, including area code)
N/A
(Former name or
former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
☐ |
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
Trading
Symbol(s) |
Name of
each exchange on which registered |
Common Stock, $0.001 par value |
GERN |
The Nasdaq Stock Market LLC |
Indicate by check
mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth
company
☐
If an emerging
growth company, indicate by check mark if the registrant has
elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02 Departure of
Directors or Certain Officers; Election of Directors; Appointment
of Certain Officers; Compensatory Arrangements of Certain
Officers.
On December 1,
2021, the Board of Directors (the “Board”) of Geron Corporation
(the “Company”) appointed Edward Koval as the Company’s Executive
Vice President and Chief Business Officer. Accordingly, the duties
and responsibilities of the Company’s Chief Business Officer have
been transferred from Melissa Kelly Behrs to Mr. Koval. Ms. Behrs
had served as the Company’s Chief Business Officer since January
2019. In connection with Mr. Koval’s appointment as Chief Business
Officer, Ms. Kelly Behrs has been appointed Executive Vice
President, Business Operations, and Chief Alliance
Officer.
Item
8.01 Other
Events.
Effective December
1, 2021, the Board designated each of the following officers of the
Company as an “officer” of the Company as such term is defined in
Rule 16a-1(f) promulgated under the Securities Exchange Act of
1934, as amended (the “Exchange Act”), and an “executive officer”
of the Company as such term is defined in Rule 3b-7 promulgated
under the Exchange Act:
Name |
|
Title |
John A.
Scarlett, M.D. |
|
Chairman, President
and Chief Executive Officer |
Olivia
K. Bloom |
|
Executive Vice
President, Finance, Chief Financial Officer and
Treasurer |
Andrew
J. Grethlein, Ph.D. |
|
Executive Vice
President and Chief Operating Officer |
Anil
Kapur, M.B.A. |
|
Executive Vice
President, Corporate Strategy, and Chief Commercial
Officer |
Aleksandra Rizo,
M.D., Ph.D. |
|
Executive Vice
President and Chief Medical Officer |
Stephen
N. Rosenfield, J.D. |
|
Executive Vice
President and Chief Legal Officer |
1
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
GERON
CORPORATION |
|
|
|
|
|
|
|
Date: |
December 2,
2021 |
|
By: |
/s/
Stephen Rosenfield |
|
|
|
|
|
Name: |
Stephen
N. Rosenfield |
|
|
|
|
|
Title: |
Executive Vice
President, Chief Legal Officer |
|
|
|
|
|
|
and Corporate
Secretary |
|
2
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2022 to May 2022
Geron (NASDAQ:GERN)
Historical Stock Chart
From May 2021 to May 2022